SecBot SecBot

BIAFW

bioAffinity Technologies, Inc.
Nasdaq· Services-Commercial Physical & Biological Research· Inc. DE· CIK 0001712762 Biotech & Drug Discovery
Warrants of bioAffinity Technologies, Inc. · BIAF stock page →
—
Market cap
$537.8K
Nano cap
1 year
−92.6%
from $38.85 · Oct 27
30 days
−61.4%
from $7.41
52-week range
$2.80–71.10
−96% from high · low Oct 23
Avg volume 20D
1.96M
Oct 8 spike 35.25M
Short interest
1.9K
≈0.2% of shares · +334.6%
Days to cover
1.0
at average volume
New fund stakes
0
Q1 2025 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read MIXED 5 reports · latest
Balance 0 bearish · 0 bullish · 1 mixed · 4 neutral oldest → newest, height = score
Avg score ·High conf. 4/5
Strongest NEUTRAL bioAffinity Technologies announced it received a notification of allowance from the Mexican Institute of…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q1 2025: 1 added (0 new), 0 trimmed or exited.

  • Short sellersBUILDING

    Short interest +334.6% to 1.9K shares. 1.0 days to cover, ≈0.2% of shares.

  • TrendDOWNTREND

    55% below its 50-day average. New closing low $2.80 on Oct 23.

Who's buying

13F· Q1 2025
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGDOUBLED48,283$9.2K
UBS Group AGADD665$199.00
CITADEL ADVISORS LLCADD39,180$45.1K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 8, 2026
Listing
Listing Status: BIAFW — Normal (was Deficient)
bioAffinity Technologies, Inc. - Warrant | Nasdaq Financial Status Indicator D → N
Aug 24, 2026
Trading halt
Halt Resumed: BIAFW — trading resumed after T3 (News and Resumption Times)
Halted 2026-08-21T23:50:00.000Z | Resumed 2026-08-24T13:05:00.000Z
Aug 21, 2026
Trading halt
Trading Halt: BIAFW — T3 (News and Resumption Times)
bioAffinity Technologies, Wt | Market: NASDAQ | Code: T3 — News and Resumption Times
Aug 21, 2026
Trading halt
Trading Halt: BIAFW — T1 (News Pending)
bioAffinity Technologies, Wt | Market: NASDAQ | Code: T1 — News Pending
Aug 7, 2026
Listing
Listing Status: BIAFW — Deficient (was Normal)
bioAffinity Technologies, Inc. - Warrant | Nasdaq Financial Status Indicator N → D

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
1,934
shares short
+334.6%
vs prior settlement
1.0
days to cover
≈0.2%
of shares outstanding
Trading halts
Aug 21, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 8, 2026 Listing status
Listing Status: BIAFW — Normal (was Deficient)
bioAffinity Technologies, Inc. - Warrant | Nasdaq Financial Status Indicator D → N
Jun 2, 2026 SEC
bioAffinity Technologies announced via an 8-K that the Society for Advanced Bronchoscopy will host a webinar on June…
8-K — Impact 2/10
May 27, 2026 SEC
bioAffinity Technologies announced it received a notification of allowance from the Mexican Institute of Industrial…
8-K — Impact 4/10
May 13, 2026 SEC
The SEC declared effective the resale registration statement (S-1, File No. 333-295465) for bioAffinity Technologies…
EFFECT — Impact 3/10
Mar 31, 2025 Inst.
UBS Group AG — DOUBLED
48,283 shares ($9.2K)
Dec 31, 2024 Inst.
UBS Group AG — ADD
665 shares ($199.00)

SecBot reports

7 filings · 0 bullish · 0 bearish · 1 mixed · 6 neutral
All BIAFW filing & press-release reports (7)